GlassScriptPhysician profile
Ellen A Crothers
NPI 1285747956
$1,081.76
in general payments reported to CMS, 2019-2025
19 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $148 · 2021: $259 · 2022: $195 · 2023: $58.82 · 2024: $172 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.40 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $154.97 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $101.97 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $95.67 | 2022-2023 | Cequa |
| Coopervision INC. | $82.45 | 2020-2025 | Myday Contact Lens |
| Biotissue Holdings INC. | $77.09 | 2019-2024 | |
| Alcon Vision LLC | $73.35 | 2020-2025 | Tryptyr, Precision 1 |
| Bausch & Lomb Americas INC. | $67.68 | 2022-2025 | Miebo, Infuse |
| Glaukos Corporation | $63.43 | 2020 | |
| Abb Con-Cise Optical Group LLC | $62.92 | 2019-2021 | |
| Allergan, INC. | $50.71 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $42.47 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $37.27 | 2019-2025 | |
| Harrow Eye, LLC | $34.73 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $32.98 | 2024-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $29.01 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $26.85 | 2019-2021 | |
| Astellas Pharma US INC | $18.82 | 2024 | Izervay |
| Thea Pharma INC. | $16.53 | 2024 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Crothers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.